<DOC>
	<DOCNO>NCT02719782</DOCNO>
	<brief_summary>Hepatocellular carcinoma ( HCC ) recurrence rate high among liver transplant patient , treatment measure limit . This study plan recruit 10 patient Hepatitis B virus ( HBV ) relate HCC underwent liver transplantation confirm recurrent HCC . The objective study ass safety , tolerability effectiveness HBV specific T cell receptor ( HBV/TCR ) redirect T cell target population .</brief_summary>
	<brief_title>TCR-Redirected T Cell Infusions Treat Recurrent Hepatocellular Carcinoma Post Liver Transplantation</brief_title>
	<detailed_description>This single arm open label trial patient recurrent HBV relate HCC liver transplantation . For patient successfully match TCR histocompatibility locus antigen ( HLA ) restriction , escalate dos HBV/TCR express autologous T cell infuse . Tests do confirm safety efficacy treatment , follow one month immediate observation period safety long-term follow period five year efficacy .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Diagnosis hepatocellular carcinoma ( HCC ) Underwent liver transplantation confirm recurrent HCC post operation Seropositive hepatitis B surface antigen No major postoperative complication Life expectancy least 12 week Ability provide inform consent Ability comply study procedure HLA profile match HLAclass I restriction element available T cell receptor Administration cell therapy , include NK , CIK , DC , CTL , CART , stem cell combine therapy kind within 3 month prior enrolment Second primary malignancy clinically detectable time consideration study enrolment Likelihood require steroid treatment period clinical trial Any concurrent liver infection hepatitis A , C D infection Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection Known Central Nervous System tumours include metastatic brain disease . Any condition unstable could jeopardise safety patient his/her compliance study Patients reproductive potential test positive serum urine pregnancy test result within 14 day prior enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>